Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Regine Sitruk-Ware
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Procedures
Physiology
Disorders
Devices
Concepts & Ideas
Anatomy
Sign-in to see full Profile
Network (preview)
10
Mauvais-Jarvis, Pierre
8
Thalabard, Jean-Christophe
7
Plu-Bureau, Geneviève
5
Tsong, Yun-Yen
4
Xu, Qin
4
Spitz, Irving
4
Maruo, Takeshi
4
Ohara, Noriyuki
4
Johansson, Elof
3
Faundes, Anibal
3
Brache, Vivian
3
Chen, Wei
3
Sivin, Irving
3
Kumar, Narender
3
Lê, Monique
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Regine Sitruk-Ware (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Lenzi E; Pluchino N; Begliuomini S; Casarosa E; Merlini S; Giannini A; Luisi M; Kumar N; Sitruk-Ware R; Genazzani A R
Central modifications of allopregnanolone and beta-endorphin following subcutaneous administration of Nestorone.
The Journal of steroid biochemistry and molecular biology 2009;116(1-2):15-20.
-
2009: Lièvre Michel; Sitruk-Ware Regine
Meta-analysis of 200 or 600 mg mifepristone in association with two prostaglandins for termination of early pregnancy.
Contraception 2009;80(1):95-100.
-
2009: Mahabadi Vahid; Amory John K; Swerdloff Ronald S; Bremner William J; Page Stephanie T; Sitruk-Ware Regine; Christensen Peter D; Kumar Narender; Tsong Yun-Yen; Blithe Diana; Wang Christina
Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men.
The Journal of clinical endocrinology and metabolism 2009;94(7):2313-20.
-
2009: Nath Anita; Sitruk-Ware Regine
Parenteral administration of progestins for hormonal replacement therapy.
The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 2009;14(2):88-96.
-
2009: Brache Vivian; Croxatto Horacio; Kumar Narender; Sitruk-Ware Regine; Cochón Leila; Schiappacasse Veronica; Sivin Irving; Muñoz Carla; Maguire Robin; Faundes Anibal
Effect of sexual intercourse on the absorption of levonorgestrel after vaginal administration of 0.75 mg in Carraguard gel: a randomized, cross-over, pharmacokinetic study.
Contraception 2009;79(2):150-4.
-
2008: Schumacher Michael; Sitruk-Ware Regine; De Nicola Alejandro F
Progesterone and progestins: neuroprotection and myelin repair.
Current opinion in pharmacology 2008;8(6):740-6.
-
2008: Sitruk-Ware Regine
Pharmacological profile of progestins.
Maturitas 2008;61(1-2):151-7.
-
2008: Liu Peter Y; Swerdloff Ronald S; Anawalt Bradley D; Anderson Richard A; Bremner William J; Elliesen Joerg; Gu Yi-Qun; Kersemaekers Wendy M; McLachlan Robert I; Meriggiola M Cristina; Nieschlag Eberhard; Sitruk-Ware Regine; Vogelsong Kirsten; Wang Xing-Hai; Wu Frederick C W; Zitzmann Michael; Handelsman David J; Wang Christina
Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis.
The Journal of clinical endocrinology and metabolism 2008;93(5):1774-83.
-
2008: Xu Qin; Ohara Noriyuki; Liu Jin; Amano Mariko; Sitruk-Ware Regine; Yoshida Shigeki; Maruo Takeshi
Progesterone receptor modulator CDB-2914 induces extracellular matrix metalloproteinase inducer in cultured human uterine leiomyoma cells.
Molecular human reproduction 2008;14(3):181-91.
-
2008: Sitruk-Ware Régine
Does estrogen therapy reduce coronary artery calcification in postmenopausal women?
Nature clinical practice. Endocrinology & metabolism 2008;4(1):12-3.
-
2008: Fu Xiao-Dong; Giretti Maria Silvia; Goglia Lorenzo; Flamini Marina Ines; Sanchez Angel Matias; Baldacci Chiara; Garibaldi Silvia; Sitruk-Ware Regine; Genazzani Andrea Riccardo; Simoncini Tommaso
Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion.
BMC cancer 2008;8():166.
-
2007: Fraser Ian S; Weisberg Edith; Kumar Narender; Kumar Sushma; Humberstone Andrew J; McCrossin Louise; Shaw Deborah; Tsong Y Y; Sitruk-Ware Regine
An initial pharmacokinetic study with a Metered Dose Transdermal Systemfor delivery of the progestogen Nestorone as a possible future contraceptive.
Contraception 2007;76(6):432-8.
-
2007: Sitruk-Ware R
New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation.
Climacteric : the journal of the International Menopause Society 2007;10(5):358-70.
-
2007: Shively Carol A; Wood Charles E; Register Thomas C; Willard Stephanie L; Lees Cynthia J; Chen Haiying; Sitruk-Ware Regine L; Tsong Yun-Yen; Cline J Mark
Hormone therapy effects on social behavior and activity levels of surgically postmenopausal cynomolgus monkeys.
Psychoneuroendocrinology 2007;32(8-10):981-90.
-
2007: Brache Vivian; Croxatto Horacio; Sitruk-Ware Regine; Maguire Robin; Montero Juan Carlos; Kumar Narender; Salvatierra Ana Maria; Tejada Ana Sofia; Cochón Leila; Forcelledo María Luisa; Lahteenmaki Pekka; Alvarez Francisco; Faundes Anibal
Effect of a single vaginal administration of levonorgestrel in Carraguard gel on the ovulatory process: a potential candidate for "dual protection" emergency contraception.
Contraception 2007;76(2):111-6.
-
2007: Wood Charles E; Sitruk-Ware Regine L; Tsong Yun-Yen; Register Thomas C; Lees Cynthia J; Cline J Mark
Effects of estradiol with oral or intravaginal progesterone on risk markers for breast cancer in a postmenopausal monkey model.
Menopause (New York, N.Y.) 2007;14(4):639-47.
-
2007: Sitruk-Ware Regine; Bossemeyer Ronald; Bouchard Phillipe
Preclinical and clinical properties of trimegestone: a potent and selective progestin.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2007;23(6):310-9.
-
2007: Maruo Takeshi; Ohara Noriyuki; Matsuo Hiroya; Xu Qin; Chen Wei; Sitruk-Ware Regine; Johansson Elof D B
Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas.
Contraception 2007;75(6 Suppl):S99-103.
-
2007: Sitruk-Ware Regine
The levonorgestrel intrauterine system for use in peri- and postmenopausal women.
Contraception 2007;75(6 Suppl):S155-60.
-
2007: Sitruk-Ware Regine; Brache Vivian; Maguire Robin; Croxatto Horacio; Kumar Narender; Kumar Sushma; Montero Juan Carlos; Salvatierra Ana Maria; Phillips David; Faundes Anibal
Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception.
Contraception 2007;75(6):454-60.
-
2007: Sitruk-Ware Régine L; Menard Joël; Rad Mandana; Burggraaf Jacobus; de Kam Marieke L; Tokay Barbara A; Sivin Irving; Kluft Cornelis
Comparison of the impact of vaginal and oral administration of combined hormonal contraceptives on hepatic proteins sensitive to estrogen.
Contraception 2007;75(6):430-7.
-
2007: Sitruk-Ware Régine; Plu-Bureau Geneviève; Menard Joël; Conard Jacqueline; Kumar Sushma; Thalabard Jean-Christophe; Tokay Barbara; Bouchard Philippe
Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study.
The Journal of clinical endocrinology and metabolism 2007;92(6):2074-9.
-
2007: Sitruk-Ware Regine
Routes of delivery for progesterone and progestins.
Maturitas 2007;57(1):77-80.
-
2006: Grunberg Steven M; Weiss Martin H; Russell Christy A; Spitz Irving M; Ahmadi Jamshid; Sadun Alfredo; Sitruk-Ware Regine
Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma.
Cancer investigation 2006;24(8):727-33.
-
2006: Palanisamy Gopinath S; Cheon Yong-Pil; Kim Jaeyeon; Kannan Athilakshmi; Li Quanxi; Sato Marcey; Mantena Srinivasa R; Sitruk-Ware Regine L; Bagchi Milan K; Bagchi Indrani C
A novel pathway involving progesterone receptor, endothelin-2, and endothelin receptor B controls ovulation in mice.
Molecular endocrinology (Baltimore, Md.) 2006;20(11):2784-95.
-
2006: Xu Qin; Ohara Noriyuki; Chen Wei; Liu Jin; Sasaki Hiroko; Morikawa Akira; Sitruk-Ware Regine; Johansson Elof D B; Maruo Takeshi
Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells.
Human reproduction (Oxford, England) 2006;21(9):2408-16.
-
2006: Sitruk-Ware Regine
Mifepristone and misoprostol sequential regimen side effects, complications and safety.
Contraception 2006;74(1):48-55.
-
2006: Rad Mandana; Kluft Cornelis; Ménard Joël; Burggraaf Jacobus; de Kam Marieke L; Meijer Piet; Sivin Irving; Sitruk-Ware Regine L
Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables.
American journal of obstetrics and gynecology 2006;195(1):72-7.
-
2006: Plu-Bureau Geneviève; Lê Monique G; Sitruk-Ware Regine; Thalabard Jean-Christophe
Cyclical mastalgia and breast cancer risk: results of a French cohort study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(6):1229-31.
-
2006: Sitruk-Ware Regine
Contraception: an international perspective.
Contraception 2006;73(3):215-22.
-
2006: Sitruk-Ware Regine
New progestagens for contraceptive use.
Human reproduction update 2006;12(2):169-78.
-
2005: Spitz Irving M; Grunberg Steven M; Chabbert-Buffet Nathalie; Lindenberg Tzina; Gelber Hadassa; Sitruk-Ware Regine
Management of patients receiving long-term treatment with mifepristone.
Fertility and sterility 2005;84(6):1719-26.
-
2005: Sitruk-Ware R
Pharmacology of different progestogens: the special case of drospirenone.
Climacteric : the journal of the International Menopause Society 2005;8 Suppl 3():4-12.
-
2005: Sitruk-Ware Regine; Inki Pirjo
The levonorgestrel intrauterine system: long-term contraception and therapeutic effects.
Women's health (London, England) 2005;1(2):171-82.
-
2005: Sitruk-Ware Regine
Estrogen and progestogens--different routes of administration.
Climacteric : the journal of the International Menopause Society 2005;8 Suppl 1():1-2.
-
2005: Sitruk-Ware Regine
Vaginal delivery of contraceptives.
Expert opinion on drug delivery 2005;2(4):729-36.
-
2005: Sitruk-Ware Regine
Delivery options for contraceptives.
Drug discovery today 2005;10(14):977-85.
-
2005: Venken Katrien; Boonen Steven; Van Herck Erik; Vandenput Liesbeth; Kumar Narender; Sitruk-Ware Regine; Sundaram Kalyan; Bouillon Roger; Vanderschueren Dirk
Bone and muscle protective potential of the prostate-sparing synthetic androgen 7alpha-methyl-19-nortestosterone: evidence from the aged orchidectomized male rat model.
Bone 2005;36(4):663-70.
-
2005: Xu Qin; Takekida Shigeki; Ohara Noriyuki; Chen Wei; Sitruk-Ware Regine; Johansson Elof D B; Maruo Takeshi
Progesterone receptor modulator CDB-2914 down-regulates proliferative cell nuclear antigen and Bcl-2 protein expression and up-regulates caspase-3 and poly(adenosine 5'-diphosphate-ribose) polymerase expression in cultured human uterine leiomyoma cells.
The Journal of clinical endocrinology and metabolism 2005;90(2):953-61.
-
2004: Ben-Chetrit Avraham; Eldar-Geva Talia; Lindenberg Tzina; Farhat Morshed; Shimonovitz Shlomo; Zacut David; Gelber Hadassa; Sitruk-Ware Regine; Spitz Irving M
Mifepristone does not induce cervical softening in non-pregnant women.
Human reproduction (Oxford, England) 2004;19(10):2372-6.
-
2004: Sitruk-Ware R; Husmann F; Thijssen J H H; Skouby S O; Fruzzetti F; Hanker J; Huber J; Druckmann R
Role of progestins with partial antiandrogenic effects.
Climacteric : the journal of the International Menopause Society 2004;7(3):238-54.
-
2004: Sitruk-Ware Regine; Plu-Bureau Genevieve
Exogenous progestagens and the human breast.
Maturitas 2004;49(1):58-66.
-
2004: Johansson Elof D B; Sitruk-Ware Regine
New delivery systems in contraception: vaginal rings.
American journal of obstetrics and gynecology 2004;190(4 Suppl):S54-9.
-
2004: Sitruk-Ware Regine
Pharmacological profile of progestins.
Maturitas 2004;47(4):277-83.
-
2004: Sitruk-Ware Régine
New progestogens: a review of their effects in perimenopausal and postmenopausal women.
Drugs & aging 2004;21(13):865-83.
-
2003: Sitruk-Ware Regine; Spitz Irving M
Pharmacological properties of mifepristone: toxicology and safety in animal and human studies.
Contraception 2003;68(6):409-20.
-
2003: Sitruk-Ware Regine
Progestins in hormonal therapy (HT) today, tomorrow and the next day: a roundtable discussion.
Steroids 2003;68(10-13):973-9.
-
2003: Sitruk-Ware Regine; Small Margaret; Kumar Narender; Tsong Yun-Yen; Sundaram Kalyan; Jackanicz Theodore
Nestorone: clinical applications for contraception and HRT.
Steroids 2003;68(10-13):907-13.
-
2003: Sitruk-Ware R L
Hormone therapy and the cardiovascular system: the critical role of progestins.
Climacteric : the journal of the International Menopause Society 2003;6 Suppl 3():21-8.
-
2003: Sitruk-Ware R
Alternatives for optimal hormone replacement therapy.
Climacteric : the journal of the International Menopause Society 2003;6 Suppl 2():11-6.
-
2003: Sitruk-Ware R
Progestins in hormonal replacement therapy (HRT): new molecules, risks and benefits.
Annales d'endocrinologie 2003;64(2):178.
-
2002: Sitruk-Ware Regine
Hormonal replacement therapy.
Reviews in endocrine & metabolic disorders 2002;3(3):243-56.
-
2002: Sitruk-Ware Régine
Progestogens in hormonal replacement therapy: new molecules, risks, and benefits.
Menopause (New York, N.Y.) 2002;9(1):6-15.
-
1999: Sitruk-Ware R
[Anti-progesterones]
Presse médicale (Paris, France : 1983) 1999;28(38):2123-31.
-
1999: Sitruk-Ware R; Plu-Bureau G
Progestins and cancer.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1999;13 Suppl 4():3-9.
-
1999: Plu-Bureau G; Lê M G; Thalabard J C; Sitruk-Ware R; Mauvais-Jarvis P
Percutaneous progesterone use and risk of breast cancer: results from a French cohort study of premenopausal women with benign breast disease.
Cancer detection and prevention 1999;23(4):290-6.
-
1997: Sitruk-Ware R; Thomas J L
[Topical hormonal treatment and urogenital atrophy]
Praxis 1997;86(33):1245-8.
-
1997: Sitruk-Ware R
[Do progestins have drawbacks?]
Contraception, fertilité, sexualité (1992) 1997;25(5):352-7.
-
1996: Sitruk-Ware R
[Comparative evaluation of oral versus non-oral hormonal treatments in menopause]
Journal de gynécologie, obstétrique et biologie de la reproduction 1996;25(7):688-93.
-
1995: Sitruk-Ware R
[Pharmacology of oral contraceptives]
La Revue du praticien 1995;45(19):2401-6.
-
1994: Plu-Bureau G; Lê M G; Sitruk-Ware R; Thalabard J C; Mauvais-Jarvis P
Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease.
British journal of cancer 1994;70(2):270-7.
-
1992: Plu-Bureau G; Thalabard J C; Sitruk-Ware R; Asselain B; Mauvais-Jarvis P
Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French women.
British journal of cancer 1992;65(6):945-9.
-
1990: Sitruk-Ware R; Thalabard J C; De Plunkett T L; Lewin F; Epelboin S; Mowszowicz I; Yaneva H; Tournaire M; Chavinie J; Mauvais-Jarvis P
The use of the antiprogestin RU486 (mifepristone) as an abortifacient in early pregnancy--clinical and pathological findings; predictive factors for efficacy.
Contraception 1990;41(3):221-43.
-
1989: Sitruk-Ware R; Thalabard J C; Benotmane A; Mauvais-Jarvis P
Risk factors for breast fibroadenoma in young women.
Contraception 1989;40(3):251-68.
-
1987: Sitruk-Ware R; Bricaire C; De Lignieres B; Yaneva H; Mauvais-Jarvis P
Oral micronized progesterone. Bioavailability pharmacokinetics, pharmacological and therapeutic implications--a review.
Contraception 1987;36(4):373-402.
-
1987: Sitruk-Ware R; Clair F; Sterkers N; Ulmann A; Mauvais-Jarvis P
Prolactin secretion in benign breast diseases.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1987;1(2):195-200.
-
1986: Thalabard J C; Sitruk-Ware R; Kuttenn F; Mauvais-Jarvis P
[Endocrine markers in benign breast diseases]
Zentralblatt für Gynäkologie 1986;108(6):354-8.
-
1985: Sitruk-Ware R; Varin C; Clair F; Maugis E; Fermanian J; Mauvais-Jarvis P
In vivo effects of progestins on prolactin secretion.
The Journal of clinical endocrinology and metabolism 1985;60(3):575-8.
-
1980: Sitruk-Ware R; de Lignieres B; Basdevant A; Mauvais-Jarvis P
Absorption of percutaneous oestradiol in postmenopausal women.
Maturitas 1980;2(3):207-11.
Sign-in to see more
